Qualitative metabolism assessment using high performance thin la

Details Qualitative metabolism assessment using high performance thin la Qualitative metabolism assessment using high performance thin la

1987-07-27

1989-10-31

Richman, Barry S.

Chemistry: analytical and immunological testing

Including chromatography

Utilizing paper or thin layer plate

436161, G01N 3090

Patent

active

048777447

ABSTRACT:
A method for the qualitative assessment of oxidative drug metabolism deficiencies, preferably for the qualitative assessment of dextromethorphan metabolism, in a subject comprises analyzing a sample fluid from the subject, for example urine, which contains metabolites of a probe drug using high performance thin layer chromatography.

REFERENCES:
patent: 3963421 (1976-06-01), Jones
patent: 4741830 (1988-05-01), Hauck et al.
"Dextromethorphan is a Safe Probe for Debrisoquine Hydroxylation Polymorphism", Kupfer, A., Schmid, B., and Preisig, R., The Lancet:517-518, Sept. 1, 1984.
"Methoxyphenamine and Dextromethorphan as Safe Probes for Debrisoquine Hydroxylation of Polymorphism", Roy, S. D., Hawes, E. M., Hubbard, J. W., McKay, G., and Midha, K. K., The Lancet:1393, Dec. 15, 1984.
"Polymorphic Dextromethorphan Metabolism: Co-Segregation of Oxidated O-Demethylation with Debrisoquine Hydroxylation", Schmid, B., Bircher, J., Preisig, R., and Kupfer, A., Clin. Pharmacol. Ther. 38 (6):618-624 (1985).
"Interindividual differences in Dextromethorphan Kinetics in Man", De Zeeuw, R. A., Jonkman, J. H. G., and Cabana, B. E., Abstr. Acta Pharmacol. et Toxicol., III World Conference on Clin. Pharmacol. & Therapeut. Stockholm (Jul. 27-Aug. 1, 1986).
"Pharmacogenetics of Dextromethorphan O-Demethylation in Man", Kupfer, A., Schmid, B., and Pfaff, G., Xenobiotica, 16(5):421-433 (1986).
Dengler Von H. J., and Eichelbaum, M., Arzneim.-Forsch./Drug Res. 27(II), Nr. 9b:1836-1844 (1977).
"A Population and Familial Study of the Defective alicyclic Hydroxylation of Debrisoquine among Egyptians", Mahgoub, A., Idle, J. R., and Smith, R. L., Xenobiotica 9 (1):51-52 (1979).
"A Family and Population Study of the Genetic Polymorphism of Debrisoquine Oxidation in a White British Population", Price Evans, D. A., Mahgoub, A., Sloan, T. P., Idle, J. R., and Smith, R. L., J. Med. Genet. 17:102-103 (1980).
"Deficient Metabolism of Debrisoquine and Sparteine", Inaba T., Otton, S. V., and Kalow, W., Clin. Pharmacol. Ther. 27:547 (1980).
"The Genetic Control of Sparteine and Debrisoquine Metabolism in Man with New Methods of Analyzing Bimodal Distributions", Evans et al, J. Med. Genet. 20:321 (1983).
"Sparteine Oxidation Polymorphism in Denmark", Brosen, K., Otton, S. V. and Gram, L. F., Acta Pharmacol et toxicol 57:357-358 (1985).
"Pharmacogenetics of Mephenytoin; A New Drug Hydroxylation Polymorphism in man", Kupfer, A. and Preisig, R., Eur. J. Clin. Pharmacol 26:753-754 (1984).
"Relationship of N-demethylation of Amiflamine and its Metabolite to Debrisoquine Hydroxylation Polymorphism", Alvan et al, Clin. Pharmacol Therap 36(4):515-517 (1984).
"Nortriptyline and Debrisoquine Hydroxylations in Ghanaian and Swedish subjects", Woolhouse et al, Clin. Pharmacol Therap 36(3):374-375 (1984).
"Mephenytoin hydroxylation deficiency in Caucasians: frequency of a New Oxidative Drug Metabolism Polymorphism", Wedlund et al., Clin. Pharmacol. and Therapeut. 36(6):773-774 (1984).
"Metoprolol Metabolism and Debrisoquine Oxidation Polymorphism-Population and Family Studies", McGourty et al, Br. J. Clin. Pharmac. 20:555-557 (1985).
"Genetic Polymorphism of Mephenytoin p(4')-Hydroxylation: difference between Orientals and Caucasians", Jurima et al, Br. J. Clin. Pharmac. 19:483-484 (1985).
"A Family Study of Genetic and Environmental Factors determining Polymorphic Hydroxylation of Debrisoquin", Steiner et al., Clin. Pharmacol. Ther. 38:394-395 (1985).
"No Evidence for The Presence of Poor Metabolizers of Sparteine in An Amerindian Group; The Cunas of Panama", Arias, et al, Br. J. Clin. Pharmac. 21:547-548 (1986).
"Co-inheritance of the Polymorphic Metabolism of Encainide and Debrisoquine", Woosley et al., Clin. Pharmacol Ther 39(3):282-285 (1986).
"Debrisoquine Oxidation in An Australian Population", Peart et al., Br. J. Clin. Pharmac. 21:465-466 (1986).
"Determination of Dextromethorphan and Metabolites in Human Plasma and Urine by High-Performance Liquid Chromatography with Fluorescence Detection", East, T. And Dye, D., J. Chromat. 338:99-112 (1985).
"The Genetic Polymorphism of Sparteine Metabolism", Eichelbaum et al., Xenobiotica, 16(5):465-475 (1986).
"Quantitative Determination of Dextromethorphan and Three Metabolites in Urine by Reverse-Phase High-Performance Liquid Chromatography", Park et al, J. Pharmaceut. Sci. 73(1):24-29 (1984).
"Determination of Dextromethorphan in Biological Fluids by Liquid Chromatography by using Semi-Microbore Columns", Achari et al, J. Pharmaceut. Sci. 73(12):1821-1822 (1984).

Affiliated with

Also associated with

Rating

Qualitative metabolism assessment using high performance thin la does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Qualitative metabolism assessment using high performance thin la, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Qualitative metabolism assessment using high performance thin la will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-625776